There is no evidence that prescribing cholesterol-lowering statins to patients at risk for, but without, heart disease reduces their chances for early death, according to a meta-analysis.
There is no evidence that prescribing cholesterol-lowering statins to patients at risk for, but without, heart disease reduces their chances of early death, according to the findings of a recent meta-analysis.
British researchers included 11 prospective, randomized, controlled trials of statin therapy in persons free from cardiovascular disease at baseline. They reviewed data on more than 65,000 participants followed for approximately 244,000 person-years, during which time 2,793 deaths occurred, including 1,447 participants using placebo and 1,346 using statins.
The use of statins was not associated with a statistically significant reduction in the risk of all-cause mortality (risk ratio, 0.91; 95% CI, 0.83-1.01). Although low-density lipoprotein cholesterol levels were lower among those participants taking statins than among those taking placebo, this finding did not translate into a reduced risk for premature death.
Mosie Baby Kit receives class 2 FDA clearance for intravaginal insemination
December 6th 2023Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.
Read More
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
How plasma biomarkers illuminate brain health in women with HIV
December 4th 2023Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.
Read More